RESUMO
O tecido ósseo, embora tenha a capacidade de regeneração, é limitado em sua eficácia diante de defeitos críticos que impedem a regeneração natural. Dessa forma, materiais como a hidroxiapatita (HA) têm sido considerados promissores na engenharia de tecido ósseo. Contudo, apesar de sua ampla utilização, a hidroxiapatita apresenta desvantagens, como a taxa de reabsorção e remodelação lenta. Em contraste, o biovidro 45S5 se destaca por sua biocompatibilidade, propriedades bioativas e degradabilidade. Este estudo objetivou avaliar o comportamento biológico in vitro e in vivo de grânulos de vidro bioativas de biovidro 45S5 fabricadas pelo método de fusão. Os biovidros foram caracterizados por meio da difração de raios X (DRX), espectroscopia de infravermelho por transformação de Fourier (FTIR), calorimetria diferencial de varredura (DSC) e espectrometria de emissão óptica com plasmas indutivamente acoplados (ICP OES). Em seguida, foi realizado o estudo in vitro, utilizando células osteoblásticas isoladas de fêmures de ratos, que foram submetidas a análise da morfologia celular (MEV), viabilidade celular (MTT), conteúdo de proteína total (PT), atividade de fosfatase alcalina (ALP) e formação de nódulos de mineralização. No estudo in vivo, foram realizados defeitos ósseos críticos de 7 mm na tíbia de coelhos da raça New Zealand, que foram divididos em dois grupos (n=6) de acordo com o material de preenchimento: hidroxiapatita comercial (HA) e biovidro 45S5 (BG45S5). Após 2, 8 e 12 semanas, os animais foram eutanasiados e as peças ósseas foram submetidas as análises histológicas e histomorfométricas. Os dados foram submetidos ao teste de normalidade Shapiro-Wilk (p=0,05) e quando normais realizamos o teste t de student e quando não normais realizamos o teste de Mann-Whitney. Os resultados dos testes físico-químicos mostraram sucesso na produção do novo biomaterial. Nos testes in vitro, observou-se que o grupo BG45S5 não apresentou citotoxicidade e mostrou-se promissor com diferença estatisticamente significante em relação ao grupo hidroxiapatita comercial (p=0.0263). Nos testes de PT, ALP e nódulos de mineralização, os grupos não apresentaram diferença estatística entre eles (p<0,05). Contudo, o grupo BG45S5 mostrou-se promissor em relação aos outros grupos. Na análise histológica, ambos os grupos apresentaram neoformação óssea nos defeitos após 2, 8 e 12 semanas. Na histomorfometria, observou-se que os grupos BG45S5 e HA apresentaram maior área de neoformação óssea em 12 semanas. Houve diferença estatisticamente significante entre os grupos no tempo de 2 semanas, com maior neoformação para o grupo BG45S5. Apesar dos resultados promissores do grupo BG45S5, não houve diferença estatisticamente significativa entre os grupos (p<0,05) nos tempos de 8 e 12 semanas. Em resumo, os resultados evidenciaram o sucesso na produção do biomaterial sintético e o potencial do biomaterial BG45S5 como um material promissor para tratamento de defeitos ósseos críticos. (AU)
Bone tissue, despite its capacity of regeneration, is limited in its effectiveness when faced with critical defects that prevent natural regeneration. Therefore, materials such as hydroxyapatite (HA) have been considered promising in bone tissue engineering. However, despite its wide use, hydroxyapatite has disadvantages, such as slow resorption and remodeling rates. In contrast, 45S5 bioglass stands out for its biocompatibility, bioactive properties and degradability. This study aimed to evaluate the in vitro and in vivo biological behavior of bioactive 45S5 bioglass beads manufactured by the melt quenched method. The bioglasses were characterized using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and inductively coupled plasma optical emission spectrometry (ICP OES). Following this, an in vitro study was conducted using osteoblastic cells isolated from rat femurs, which were subjected to analysis of cell morphology (SEM), cell viability (MTT), total protein content (TP), alkaline phosphatase activity (ALP) and mineralization nodule formation. In the in vivo study, critical bone defects of 7 mm were created in the tibia of New Zealand rabbits, which were divided into two groups (n=6) according to the filling material: commercial hydroxyapatite (HA) and bioactive glass 45S5 (BG45S5). After 2, 8, and 12 weeks, the animals were euthanized and the bone pieces were subjected to histological and histomorphometric analyses. Data were subjected to the Shapiro-Wilk normality test (p=0.05), and when normal, we performed the Student's t-test, and when non-normal, we performed the Mann-Whitney test. The results of the physicochemical tests showed success in the production of the new biomaterial. In the in vitro tests, it was observed that the BG45S5 group did not present cytotoxicity and showed promise with a statistically significant difference compared to the commercial hydroxyapatite group (p=0.0263). In the TP, ALP and mineralization nodule tests, the groups showed no statistical difference between them (p<0.05). However, the BG45S5 group showed promise compared to the other groups. In the histological analysis, both groups showed new bone formation in the defects after 2, 8, and 12 weeks. In the histomorphometric analysis, it was observed that the BG45S5 and HA groups presented a larger area of new bone formation at 12 weeks. There was a statistically significant difference between the groups at 2 weeks, with greater new formation for the BG45S5 group. Despite the promising results of the BG45S5 group, there was no statistically significant difference between the groups (p<0.05) at 8 and 12 weeks. In summary, the results evidenced the successful production of the synthetic biomaterial and the potential of the BG45S5 bioglass as a promising material for treating critical bone defect.(AU)
Assuntos
Materiais Biocompatíveis , Osso e Ossos , Regeneração ÓsseaRESUMO
Bioactive glass (BG)-based scaffolds of 45S5 composition covered with hydroxyapatite nanoparticles loaded with Mg2+, Zn2+ and, both Mg2+ and Zn2+ ions, were developed and tested as materials for tissue engineering applications. The scaffolds were prepared by the foam replica technique and mono- and bi-metal loaded and unloaded hydroxyapatite nanoparticles (HA, Zn-HA, Mg-HA and Mg-Zn-HA) were obtained by an adaptation of the wet chemical deposition method. Coating of BG with these nanoparticles was performed by dip-coating to obtain HA-BG, Zn-HA-BG, Mg-HA-BG and Mg-Zn-HA-BG scaffolds. As predictor of the bone bonding ability of the produced scaffolds, in this study we investigated the formation of an apatite layer on the scaffold surfaces in the presence of simulated body fluid. The cytotoxicity and osteogenic properties of the materials in vitro was evaluated using human osteoblast-like MG-63 cell cultures. The mineralization assay following Kokubo's protocol indicated that bi-metal loaded Mg-Zn-HA-BG scaffolds exhibited higher/faster bioactivity than mono-metal loaded scaffolds while mineralization of HA-BG, Zn-HA-BG and Mg-HA-BG was similar to that of uncoated scaffolds. Moreover, an increase of proliferation of MG-63 cells after 48â¯h and 7 days was measured by BrdU assays for Mg-Zn-HA-BG scaffolds. In agreement with these results, SEM images confirmed increased interaction between these scaffolds and cells, in comparison to that observed for mono-metal-loaded HA-coated scaffolds. Altogether, the obtained results suggest that nanocrystalline Mg-Zn-HA coatings enhance the biological performance of standard scaffolds of 45S5 BG composition. Thus these novel ion doped HA coated scaffolds are attractive systems for bone tissue engineering.
Assuntos
Cerâmica/química , Materiais Revestidos Biocompatíveis/química , Durapatita/química , Vidro/química , Magnésio/química , Osteoblastos/efeitos dos fármacos , Alicerces Teciduais , Zinco/química , Materiais Biomiméticos/química , Materiais Biomiméticos/farmacologia , Líquidos Corporais/química , Adesão Celular/efeitos dos fármacos , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Cerâmica/farmacologia , Materiais Revestidos Biocompatíveis/farmacologia , Durapatita/farmacologia , Humanos , Nanopartículas/química , Osteoblastos/citologia , Osteoblastos/fisiologia , Osteogênese/efeitos dos fármacos , Engenharia Tecidual/métodosRESUMO
INTRODUCTION: The use of bioactive glasses to re-establish or increase mechanical properties of the root dentin may be an interesting alternative. The aim of this study was to evaluate the effect of root repair materials and bioactive glasses on the microhardness of human root dentin. METHODS AND MATERIALS: Sixty-four sectioned palatal roots of human molars were prepared and two slices were obtained of the middle third of each root (one corresponding to the control group, without treatment, and the other to the experimental group). The pairs of slices were randomly divided into four groups (n=16). The root canal of experimental slices were filled with one of the following materials: mineral trioxide aggregate (Angelus MTA, Angelus, Londrina, Paraná, Brazil), EndoSequence Root Repair Material (ERRM, Brassler, Savannah, GA, USA), Bioglass (45S5) and an experimental niobophosphate glass (NbG). The specimens were stored in an oven at 37ºC, in an environment with 100% humidity for 60 days. The specimens were subjected to a microhardness test. Four indentations were made at a distance of 20 µm from the root canal lumen. For microhardness analysis, comparing the experimental groups and their respective controls, the Student's-t test was applied. For comparison of the percentage increase in microhardness between the groups, the data were statistically analyzed by using One-way ANOVA and Tukey's test. The level of significance was set at 0.05. RESULTS: All the materials significantly increased the dentin microhardness values (P<0.05). MTA showed a higher increase in microhardness (94.8±42.7%), similar to that of EndoSequence (62.3±39.9%). The 45S5 (46.5±30.0%) and NbG (53.8±31.3%) showed the lowest percentages of increase in microhardness, but were statistically similar to those of EndoSequence. CONCLUSION: All the materials tested were capable of increasing root dentin microhardness.
RESUMO
RESUMEN: Andamios macroporos de biovidro 45S5 han sido desarrollados como una alternativa para sustituir injertos de hueso tradicionales. Un factor crucial en el diseño de estos andamios es la permeabilidad ya que de esto dependerá su capacidad para remover desechos y suministrar nutrientes y oxígeno a las células. En este trabajo se llevó acabo la evaluación de la permeabilidad basados en la ley de Darcy de andamios macroporos de biovidrio 45S5 con porosidades en el rango de 69-74%. Los valores de permeabilidad obtenidos fueron de 4.19 × 10-10, 3.75 × 10-10 y 3.48 × 10-10 m 2 que estuvieron en el rango de los valores de permeabilidad del hueso trabecular.
ABSTRACT: Bioactive glass 45S5 foams were produced as an alternative to be used to fill and restore bone defects. A crucial design factor of foams is permeability, since it is related to their capability for waste removal and nutrients/oxygen supply to cells. In the present work a study was carried out to analyze the bioactive glass 45S5 foams permeability by Darcy's law. In the present work a study was carried out to analyze the bioactive glass 45S5 foams permeability by Darcy's law. The measure average permeability value on foams of 69-74 % porosity was 4.19 × 10-10, 3.75 × 10-10 y 3.48 × 10-10 m 2 , which are in the range of permeability values for trabecular bone.
RESUMO
Abstract This study evaluated pH and release of calcium, sodium and phosphate ions from different medications in human dentin. Fifty premolars were prepared and randomly divided into groups: (CHX) - 2% chlorhexidine gel; (CHX + CH) - CHX + calcium hydroxide PA; (CH) - CH + propylene glycol 600; (NPBG) - experimental niobium phosphate bioactive glass + distilled water; (BG) - bioactive glass (Bio-Gran) + distilled water. The specimens were immersed in deionized water and the pH variations were measured. The quantification of ions in the solutions was made by inductively coupled plasma - atomic emission spectroscopy (ICP/AES) at 10 min, 24 h, 7, 14, 21 and 30 days. The results were analyzed by ANOVA and Tukey`s test, with a significance level of 5%. CH had the highest level of calcium ions release at 30 days, while CHX and BG released more sodium ions. BG, NPBG and CHX released a higher amount of phosphate ions. The pH of CH was significantly higher compared with the other groups. CH favored the greatest increase of pH and calcium ions release. The bioactive glasses released more sodium and phosphate ions and presented an alkaline pH immediately and after 30 days.
Resumo Este estudo avaliou o pH e a liberação de íons cálcio, sódio e fosfato de diferentes medicamentos em dentina humana. Cinquenta pré-molares foram preparados e divididos aleatoriamente em grupos: (CHX) - clorexidina gel 2%; (CHX + CH) - CHX + hidróxido de cálcio PA; (CH) - CH + propilenoglicol 600; (NPBG) - vidro experimental nióbio fosfato bioativo + água destilada; (BG) - vidro bioativo (Bio-Gran) + água destilada. Os espécimes foram submersos em água deionizada e as variações de pH foram mensuradas. A quantificação dos íons nas soluções foi feita por espectrometria de emissão atômica com plasma indutivamente acoplado (ICP - AES) nos tempos de 10 min, 24 h, 7, 14, 21 e 30 dias. Os resultados foram analisados por ANOVA e teste Tukey, com um nível de significância de 5%. Verificou-se que CH a teve a maior liberação íons de cálcio ao final de 30 dias, enquanto CHX e BG liberaram mais íons de sódio. BG, NPBG e CHX apresentaram a maior liberação de íons fosfato. O pH de CH foi significativamente maior em comparação com os outros grupos testados. O grupo CH aumentou o pH e a liberação de íons cálcio. Os vidros bioativos obtiveram uma maior liberação de íons sódio e fosfato e apresentaram pH alcalino imediato e ao final de 30 dias.
Assuntos
Humanos , Hidróxido de Cálcio/química , Cálcio/metabolismo , Clorexidina/química , Vidro , Concentração de Íons de Hidrogênio , Tratamento do Canal Radicular , Microscopia Eletrônica de VarreduraRESUMO
Different techniques and materials can be used to treat intrabony periodontal defects caused by periodontal diseases. This case report presents an intrabony periodontal defect with bioactive glass and connective tissue graft used as a barrier. Probing depth and clinical attachment gain were reduced at 6 and 12 months post-treatment.